The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

  1. Muñoz, M.
  2. González-Ortega, A.
  3. Salinas-Martín, M.V.
  4. Caranza, A.
  5. Garcia-Recio, S.
  6. Almendro, V.
  7. Coveñas, R.
Journal:
International Journal of Oncology

ISSN: 1791-2423 1019-6439

Year of publication: 2014

Volume: 45

Issue: 4

Pages: 1658-1672

Type: Article

DOI: 10.3892/IJO.2014.2565 GOOGLE SCHOLAR lock_openOpen access editor